Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

Also called NCT04704986

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 202 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04704986
Other papers using this trial's data
  • PolarX vs Arctic Front for Cryoballoon Ablation of Paroxysmal AF: The Randomized COMPARE CRYO Study JACC. Clinical electrophysiology, 2024-07 DOI, PubMed 38752963

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04704986. Randomized; no masking; primary purpose treatment. Start 2021-03-29 (actual); primary completion 2023-07-31 (actual). Results posted on 2026-07-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF
Acronym
COMPARE-CRYO
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
PVI using the Arctic Front Cryoballoon (Medtronic)
Intervention (Drug)
PVI using the PolarX Cryoballoon (Boston Scientific)
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
University Hospital, Basel, Switzerland (class: other)

Record details

Record id
cardio:ct-nct04704986
Content hash
2ffbc908cdc0aa085e39f68c49fb458ca016073f2b38122c06ebe7defb8bc9c7